TIS tissue therapies limited

Since the EMA review is all about manufacturing I think the...

  1. 347 Posts.
    Since the EMA review is all about manufacturing I think the delay in announcing the CHMP meeting outcome is due to Mercer and his team liaising with Catalent etc on what is needed, how it can be obtained and how long it will take to get the info.

    the longer this takes the more complicated the outstanding issues must be.

    Not looking good.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.